Evidence map›Paper›PMID 37413696›Full record

ArticleAmerican journal of respiratory and critical care medicine2023

Prostaglandin I

Allison E Norlander, Masako Abney, Jacqueline-Yvonne Cephus, Caroline E Roe, Jonathan M Irish, Nicholas J Shelburne, Dawn C Newcomb, Anna R Hemnes, R Stokes Peebles

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Prostaglandin IThe Journal of allergy and clinical immunology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Reply to YasumaAmerican journal of respiratory and critical care medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Allison E NorlanderDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.ORCID 0000-0002-9357-485X
Masako AbneyDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.
Jacqueline-Yvonne CephusDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.
Caroline E RoeDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Jonathan M IrishDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Nicholas J ShelburneDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.
Dawn C NewcombDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.
Anna R HemnesDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.ORCID 0000-0002-2755-5845
R Stokes PeeblesDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and.

Funding

Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Tina V Hartert · 2011 to 2026
$34.9M
Role of Gender in TH17-Mediated Inflammation in Severe AsthmaR01HL122554 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NEWCOMB, DAWN C · 2015 to 2024
$5.5M
Genomic and Circulating Predictors of PAH responseR01HL142720 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Anna R Hemnes · 2019 to 2026
$5.0M
Targeting TH17 cell metabolism in steroid resistanceR01HL136664 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NEWCOMB, DAWN C, RATHMELL, JEFFREY C. · 2017 to 2024
$4.2M
PGI2 augments Treg functionR01AI145265 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEBLES, RAY STOKES · 2019 to 2023
$2.7M
GLP-1R signaling in allergic inflammationR01AI124456 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NISWENDER, KEVIN D, PEEBLES, RAY STOKES · 2017 to 2021
$2.2M
PGI2 regulation of TSLP-mediated allergic inflammation in the lungR01AI111820 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEBLES, RAY STOKES · 2014 to 2018
$2.0M
PGI2 restrains immunopathogenesis in hypertensionR00HL159594 · NHLBI · TRUSTEES OF INDIANA UNIVERSITY · PI NORLANDER, ALLISON ELIZABETH · 2023 to 2025
$747k
Mentorship in Pulmonary Vascular DiseaseK24HL155891 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Anna R Hemnes · 2022 to 2026
$573k
Host genetics of allergen-induced lung TSLP expression and ILC2 functionR21AI145397 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEBLES, RAY STOKES · 2019 to 2020
$468k
PGI2 restrains immunopathogenesis in hypertensionK99HL159594 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NORLANDER, ALLISON ELIZABETH · 2021 to 2022
$276k
The Effect of PGI2 on T regulatory Cell Function in Allergic DiseaseF32AI143005 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NORLANDER, ALLISON ELIZABETH · 2019 to 2020
$88k
BLRD VA I01 BX004299NHLBI NIH HHS K24 HL155891NHLBI NIH HHS K99 HL159594NHLBI NIH HHS R01 HL142720NIAID NIH HHS F32 AI143005NIAID NIH HHS R01 AI111820NIAID NIH HHS R01 AI124456NIAID NIH HHS R01 AI145265NIAID NIH HHS R21 AI145397NIAID NIH HHS U19 AI095227
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hypertension, PulmonaryPulmonary Arterial HypertensionEpoprostenolFamilial Primary Pulmonary HypertensionHumansT-Lymphocytes, RegulatoryEpoprostenol

Identifiers

PMID37413696
PMCPMC10515570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.